Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth Hormone Replacement Therapy in Veterans With mTBI and AGHD
NCT04867317Phase 3Recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Jan 2025
- Primary completion
- Feb 2027
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in adult growth hormone deficiency (AGHD), sponsored by VA Office of Research & Development. Started Jan 2025; status: recruiting.
02
Drugs
somatropin
03
Conditions
adult growth hormone deficiency (AGHD)
Beyond the preview
Go deeper on NCT04867317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04867317.